Recap: Experts at Mount Sinai Grapple With Best Practices in Multiple Myeloma

Press/Media

Period	27 Dec 2022

Media coverage

1

Media coverage

Title	Recap: Experts at Mount Sinai Grapple With Best Practices in Multiple Myeloma
Media name/outlet	Cancernetwork.com
Country/Territory	United States
Date	27/12/22
URL	ct.moreover.com/?a=49606128934&p=1gw&v=1&x=gpWJpCnzKlvyo3rCFnvf3g
Persons	Sundar Jagannath, Joshua Richter

Related content

Research Output
Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: The GRIFFIN trial
Research output: Contribution to journal › Article › peer-review
Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)
Research output: Contribution to journal › Article › peer-review